Cargando…
Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397)
AIMS: The MRC RT01 trial used conformal radiotherapy to the prostate, a method that reduces the volume of normal tissue treated by 40–50%. Because of the risk of geographical miss, the trial used portal imaging to examine whether treatment delivery was within the required accuracy. MATERIAL AND METH...
Autores principales: | Stanley, S., Griffiths, S., Sydes, M.R., Moore, A.R., Syndikus, I., Dearnaley, D.P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568874/ https://www.ncbi.nlm.nih.gov/pubmed/18565744 http://dx.doi.org/10.1016/j.clon.2008.04.019 |
Ejemplares similares
-
Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)
por: Syndikus, Isabel, et al.
Publicado: (2010) -
Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial
por: Kass-Iliyya, Antoine, et al.
Publicado: (2018) -
Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397)
por: Lemanska, Agnieszka, et al.
Publicado: (2017) -
Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer
por: Lemanska, A., et al.
Publicado: (2018) -
Reproducibility of patient setup by surface image registration system in conformal radiotherapy of prostate cancer
por: Krengli, Marco, et al.
Publicado: (2009)